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Metastases to the spine can involve the bone, epidural space, leptomeninges, and spinal cord. The spine is the third most common
site for metastatic disease, following the lung and the liver. Approximately 60–70% of patients with systemic cancer will have spinal
metastasis. Materials/Methods. This is a review of the imaging techniques and typical imaging appearances of spinal metastatic
disease. Conclusions. Awareness of the diﬀerent manifestations of spinal metastatic disease is essential as the spine is the most
common site of osseous metastatic disease. Imaging modalities have complimentary roles in the evaluation of spinal metastatic
disease. CT best delineates osseous integrity, while MRI is better at assessing soft tissue involvement. Physiologic properties,
particularly in treated disease, can be evaluated with other imaging modalities such as FDG PET and advanced MRI sequences.
Imaging plays a fundamental role in not only diagnosis but also treatment planning of spinal metastatic disease.
1.Introduction
Metastases to the spine can involve the bone, epidural space,
leptomeninges, and spinal cord. The spine is the third most
common site for metastatic disease, following the lung and
the liver [1] and the most common osseous site [2]. Approxi-
mately60–70%ofpatientswithsystemiccancerwillhavespi-
nal metastasis. Fortunately, only 10% of these patients are
symptomatic.Thefrequencywithwhichspinemetastasesare
detected varies considerably with the type of primary tumor.
Common tumors with a high rate of metastasis to bone in-
clude tumors of the breast (72%), prostate (84%), thyroid
(50%), lung (31%), kidney (37%), and pancreas (33%). To-
gether, these account for more than 80% of primary tumors
in patients presenting with metastases [3, 4]. The extradural
lesions account for up to 95% of spinal lesions and can be
dividedintopureepidurallesionsandthoseoriginatingfrom
the vertebra extending to the epidural space and subsequen-
tlyimpingingonthethecalsac[5].Thethoracicspineismost
commonly involved. Intradural extramedullary and intra-
medullary seeding of systemic cancer is unusual, accounting
for 5–6% and 0.5–1% of spinal metastases, respectively. In
general, the prognosis for patients presenting with bone
metastases is poor [6].
2.ImagingTechniquesandPitfalls
2.1. Radiography. Radiographs are an ubiquitous modality
for the evaluation of back or neck pain in the setting of trau-
maorintheevaluationofdegenerativechanges.However,X-
rays necessitate a 1cm diameter mass and 50% bone mineral
loss at minimum for detection. Up to 40% of lesions will be
unidentiﬁed by X-rays, presenting false-negative results [7]
(Figure 1). Radiography may be a crude assessment of the
risk of pathologic fracture, which is said to be high if 50%
of the cortex is destroyed by tumor [6]. Epidural lesions may
demonstrate osseous erosion along the posterior vertebral
body margin or pedicles. Rarely, metastases may cause scal-
loping of the adjacent bone.
2.2. Nuclear Medicine. Nuclear medicine bone scans (bone
scintigraphy) have been the standard initial imaging method
for screening for skeletal metastases. Tracer accumulates in
the reactive new bone that is formed in response to the lesion
(Figure 2). The amount of accumulation is sensitive to the
level of blood ﬂow. Although most metastatic lesions are
“hot,” lesions that are cold due to the complete absence of
reactive bone or poor blood ﬂow may be encountered in2 International Journal of Surgical Oncology
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Figure 1: (a) Lateral radiograph is poor at delineating the L3 ver-
tebralbodymetastaticlesion,whichappearsasafaintlucencywitha
subtle sclerotic margin (yellow arrow). (b) This lesion is better seen
onthesagittalT1-weightedMRIasanill-deﬁnedhypointensity(red
arrow) within the L3 marrow.
particularly aggressive metastases. Diﬀuse accumulation of
tracerthroughouttheskeleton(superscan)mayoccasionally
occurindisseminatedskeletaldisease,leadingtothefalseim-
pression of a normal scan. This is most common with pros-
tate carcinoma. False-negative studies are most common
with multiple myeloma (up to 25% of cases), leukemia, and
anaplastic carcinomas. Single-photon-emission computed
tomography (SPECT) scanning. SPECT imaging has im-
proved both the sensitivity and the speciﬁcity of bone scan-
ning [8], particularly with larger lesions and cortical involve-
ment. Because tracer accumulation may occur at any skeletal
site with an elevated rate of bone turnover, radionuclide up-
take may be nonspeciﬁc and may accompany trauma, infec-
tion, arthropathy, or osteopenia of disuse. In a patient with
a known primary tumor, a scan showing multiple lesions
strongly suggests metastases. However, only 50% of solitary
foci represent metastases, even in patients with cancer [6].
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Figure 2: Anterior and posterior bone scan planar images reveal
multiple foci of increased radionuclide uptake, not only in the thor-
acic and lumbar spine but also in the ribs and sacrum (yellow
arrows).
Positive scans should be correlated with contemporaneous
radiographs because of this lack of speciﬁcity.
[18F]ﬂuoro-2-deoxy-d-glucose positron emission tomo-
graphy (FDG-PET) can detect increased glucose metabolism
of neoplastic cells nested in the bone marrow, making it
a sensitive method for assessment of bone and bone marrow
metastases. [18F]-FDG PET alone and [18F]-FDG PET re-
gistered with CT have a reported sensitivity of 74% and 98%,
respectively, in the detection of spinal metastasis [9]. [18F]-
FDGPETisreportedlymoresensitivethanbonescintigraphy
in patients with lung cancer and lymphoma and was shown
to detect early bone marrow involvement before cortical
changes could be seen by bone scintigraphy [10, 11]. [18F]-
FDG PET is more sensitive for detection of osteolytic meta-
stasis than of osteoblastic metastasis [12]. Schmitz et al.
demonstratedthat[18F]-FDGPETisabletodiﬀerentiatebet-
ween osteoporotic and malignant vertebral compression
fractures in patients with [18F]-FDG-avid tumors [13].
2.3. Computed Tomography. Computed tomography (CT)
scans can recognize a bony metastatic lesion up to 6
months earlier than an X-ray [7]. CT gives superb osseous
delineation and enables detection of cortical destruction
(Figure 3). An epidural mass may present as amorphous soft
tissue displacing the thecal sac or ﬁlling the neural foramen
(Figure 4).
Although 16/64-row-MDCT provides excellent image
quality and a high spatial resolution in the assessment of
bony structures, metastatic lesions without signiﬁcant bone
destruction may be missed. Buhmann et al. found the diag-
nostic accuracy of MRI (98.7%) to be signiﬁcantly superior
to 16/64-row-MDCT (88.8%) for the detection of osseous
metastases [14]. Sensitivity was signiﬁcantly lower for
MDCT (66.2%) than for MRI (98.5%) (P<0.0001). The
speciﬁcity was not signiﬁcantly diﬀerent for both methods
(MDCT: 99.3%; MRI: 98.9%). One disadvantage of CT is the
beaming hardening artifact that obscures the adjacent softInternational Journal of Surgical Oncology 3
Figure3:SagittalCTreformationinbonealgorithmdepictsacorti-
cal break in the posterior cortex of the L3 vertebral body (yellow
arrow) due to a metastatic focus.
Figure 4: Axial CT in soft tissue algorithm displays slightly hyper-
dense soft tissue in the ventrolateral epidural space ﬁlling the left
neuralforamen(yellowarrow)andcausingmasseﬀectonthethecal
sac.
tissuesandbones.AnotherdisadvantageofCTisthatcortical
destruction may be diﬃcult to detect when osteoporosis or
degenerative changes occur [15]. Finally, there is an inherent
associated risk of radiation exposure from the CT.
2.4. CT Myelography. CT myelography is a helpful tech-
nique in those patients who cannot undergo an MRI (e.g.,
patients with pacemakers, extreme claustrophobia). It allows
assessment of osseous integrity as well as the thecal sac con-
tents and has the added beneﬁt of allowing CSF sampling at
the same time as the diagnostic test is performed. Soft tissue
characterization is better performed with MRI. CT myelog-
raphy may show metastatic disease as thickened nerve roots,
subarachnoid masses, and/or blockage of the subarachnoid
space.
2.5. Magnetic Resonance Imaging. Unlike CT, which detects
bony abnormalities, particularly cortical destruction, mag-
netic resonance (MR) imaging can detect early bone marrow
deposits (Figure5).Studies haveshownthatMRimaging has
a signiﬁcant impact on spinal tumor evaluation [16]. Speci-
ﬁc relevant diagnostic information that can be gleaned from
MRimagingofthespineincludesthediagnosisofmetastasis,
the characterization of the levels of involvement, and the
diagnosis of any associated cord compression. Both bony
involvement and neural compression from epidural tumor
are demonstrable by MR imaging. MRI is the only imaging
technique that allows direct visualization of bone marrow
and its components with high spatial resolution. The com-
bination of unenhanced T1-weighted-spin echo- and STIR-
sequences have shown to be most useful for the detection
of bone marrow abnormalities and are able to discriminate
benign from malignant bone marrow changes. Because of its
sensitivity to bone marrow abnormalities, MRI may serve to
guide biopsy of areas of abnormal signal intensity [17].
2.6. MR Sequences. Normal marrow contains both fat and
water (yellow marrow 80% fat, but also 15% water, and red
marrow 40% fat and 40% water). In inﬁltrative disorders,
fat disappears in a diﬀuse, disseminated or solitary way. Seq-
uencesdisplayingdiﬀerencesbetweenfatandwatersignalare
thus useful.
2.7. T1-Weighted Spin-Echo (SE) Sequences. Fat has a shorter
signal than water and the highest signal. Thus, fatty marrow
containing 80% fat exhibits a high signal and any focal
lesion showing a lower signal is easy to detect. This explains
why this sequence is very useful and usually the ﬁrst used.
Hematopoietic marrow, containing water but also fat, is
hypointense to fat, but hyperintense to normal muscles. At
1.5T, a marrow signal which is hypointense to the muscles
and discs in the spine is abnormal with an accuracy of 94%
and 98%, respectively [18]. The study by Zhao et al. show-
edahigherdiagnosticaccuracyusingsignalintensityofmus-
cle (89%) versus disk (78%) at 3T ﬁeld strength [19]. Re-
placement of the bone marrow always appears hypointense
relative to normal marrow on T1-weighted images [17, 20];
however, this hypointensity is nonspeciﬁc. Extensive replace-
ment of the vertebral bone marrow may initially create the
impression of a normal study (Figure 5).
2.8. T2-Weighted Sequences. Conventional spin echo (SE)
and fast spin echo T2 sequences have been shown to detect
the same number of lesions [21] with the latter being a much
more rapid sequence. On T2-weighted images, metastatic4 International Journal of Surgical Oncology
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Figure 5: Sagittal T1-weighted MR image (a) of the thoracic spine illustrates diﬀuse marrow hypointensity, which is slightly hypointense
relative to the discs. Given the diﬀuse marrow involvement, it may be diﬃcult to discern this marrow abnormality. Gadolinium-enhanced
T1-weighted MR image (b) depicts multiple heterogeneously enhancing lesions (yellow arrows). The STIR MR image (c) shows abnormally
increased signal in the posterior elements and the vertebral bodies. A compression fracture is seen in the upper thoracic spine (red arrow).
Figure 6: Sagittal T2-weighted MR image depicts the “halo sign”
with a hypointense metastatic lesion and a surrounding hyperin-
tense rim in the L3 vertebral body (yellow arrow).
lesions are usually much brighter than bone marrow, due to
their high water content. Metastases often (but not consis-
tently) have a rim of bright T2 signal around them (a halo
sign) [22] (Figure 6). The halo sign and diﬀuse signal hyper-
intensity were shown to be a strong indicator of metastatic
disease (sensitivity, 75%; speciﬁcity, 99.5%). The bull’s-eye
sign (focusof high signal intensity in the centerof an osseous
lesion) is a speciﬁc indicator of normal hematopoietic mar-
row (sensitivity, 95%; speciﬁcity, 99.5%) [22].
Contrast is typically administered in standard tumor
imaging as it allows for identiﬁcation of intramedullary and
intradural extramedullary abnormalities and extradural lesi-
ons (particularly in the epidural space) that may result in
compression of the spinal cord and alter treatment [23]
(Figure 7). However, on T1-weighted sequences, enhancing
metastases may become isointense with normal bone mar-
row and become obscured. Sequences that suppress the sig-
nal intensity of normal fatty bone marrow allow clear identi-
ﬁcation of the enhancing metastatic foci [24]. T1 postcon-
trast with fat saturation can increase the conspicuity of en-
hancing marrow lesions by suppressing the background
bright fatty marrow signal.
2.9.FatSuppressionTechniques. A180inversionpulseisused
initially for short tau inversion recovery (STIR) sequences
[25]. The inversion time is chosen to cancel the signal of
fat. This sequence can be obtained on any MR unit, but it
is unfortunately time consuming and only a limited number
of slices can be acquired. This can be overcome by using fast
STIR sequences.
Although the conspicuousness of lesions is similar on
fat-saturation T2-weighted and STIR images, the former
sequence has several practical advantages, including acqui-
sition of more slices per unit time and improved tissue speci-
ﬁcity [25]. The combination of T1-weighted and either fat-
saturation T2-weighted or STIR images is highly eﬀective for
the evaluation of bone marrow lesions. On fat-suppressed,
T1-weighted images, metastases demonstrate mixed-to-high
signal intensity, whereas nonneoplastic lesions have low sig-
nal intensity [26]. Fat saturation techniques are particularly
sensitive to susceptibility artifact from spinal hardware.
2.10. Diﬀusion-Weighted Imaging (DWI). DWI evaluates the
tissue-speciﬁc molecular diﬀusion of protons. In tissues withInternational Journal of Surgical Oncology 5
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Figure 7: Sagittal T1-weighted MR image (a) shows a hypointense expansile lesion involving the C4 and C5 vertebral bodies with extension
into the ventral epidural space (yellow arrow). The lesion enhances homogeneously on postcontrast T1-weighted MR (b); however, the
degree of normal marrow enhancement is similar to that of the metastatic myeloma lesion.
high cell densities (neoplasm), a decreased ADC can be ex-
pectedduetorestricteddiﬀusionaccordingtoanexaggerated
amount of intra- and intercellular membranes (i.e., diﬀusion
barriers). The utility of DWI on diﬀerentiating benign from
metastaticspinallesionsiscontroversialintheliterature.One
study using DWI found all benign vertebral compression
fractures from hypo- to isointense to adjacent normal verte-
bral bodies and pathologic compression fractures were
hyperintense to normal vertebral bodies [20]. However,
Castillo et al. show in their series of 15 patients that DWI
ofthespineshowednoadvantageinthedetectionandchara-
cterizationofvertebralmetastasesascomparedwithnoncon-
trast T1-weighted imaging, but was considered superior to
T2-weighted imaging [27]. Others have demonstrated that
rather than qualitative assessment, the quantitative evalua-
tion of the ADC in vertebral bodies may be an objective and
comparable parameter for diﬀerentiating malignant from
benign vertebral tissue [28].
Unfortunately, MRI often cannot distinguish among
changes that are due to treatment, fracture, and tumor.
Hanna et al. compared MRI scans with histologic specimens
at 21 sites, 7 of which contained tumor and 14 of which did
not. For all of the tumor positive sites, abnormalities were
revealed on MRI scans. However, for the sites shown to be
free of tumor, there was a signiﬁcant false-positive rate, pre-
sumably because tumor could not be distinguished from the
eﬀects of treatment [29]. DWI sequences may show decreas-
ed signal intensity of metastatic disease of the vertebral mar-
row with successful treatment [30].
2.11. Whole Body MRI. Whole-body MRI represents a
new alternative to the stepwise multimodality concept for
the detection of metastatic disease, multiple myeloma, and
lymphoma of the bone with high diagnostic accuracy [24].
The introduction of a rolling platform mounted on top of
a conventional MRI examination table facilitates whole body
MR imaging and—with the use of fast gradient echo,
T1-weighted, and STIR-imaging techniques—allows whole
body imaging within less than one hour. With the devel-
opment of parallel imaging techniques in combination with
global matrix coil concepts, acquisition time is reduced sub-
stantially without compromises in spatial resolution, enabl-
ing the implementation of more complex and ﬂexible exa-
mination protocols.
3.Pathology
Bone destruction, secondary to metastases, is caused by the
activation of osteoclasts rather than by the direct destruction
of bone by tumor cells. Mundy and Yoneda proposed that
cells from the primary site migrate or through the process of
neovascularization attach to the basement membrane of the
vessel wall and produce proteolytic enzymes that disrupt the
basement membrane [31]. The tumor cells then migrate to a
distant site hematogenously attaching to the basement mem-
brane of the vessel wall using proteolytic enzymes (integrins/
cadherins).Afterdisruptingthereceptorsitebasementmem-
brane, they migrate into the substance of the distal host tis-
sue. Producing the chemotactic factors, as well as RANK lig-
and, these cells stimulate osteoclast activity to produce bone
resorption. A feedback relationship, such as that present in
myelomacells,producescontinuedosteoclaststimulationfor
bone resorption and tumor cell growth. This continued
growth and survival of the metastatic cells progressively des
troys cancellous and cortical bone at the distant osseous site.
Primary tumors which typically have lytic spinal metas-
tases are breast, lung, kidney, thyroid, oropharyngeal, mela-
noma, adrenal, and uterus. Breast and lung cancer may also6 International Journal of Surgical Oncology
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Figure 8: Sagittal CT reformation (a) shows multiple lytic and blastic metastatic breast cancer lesions in the thoracic spine with a compres-
sion fracture in the upper thoracic spine (yellow arrow). Sagittal T1-weighted image (b) shows multiple hypointense lesions, many of which
enhance on the postcontrast T1-weighted MR (c). The STIR image (d) depicts both hyperintense (lytic) and hypointense (blastic) lesions. A
mildly enhancing epidural component compresses the thecal sac (red arrows).
(a) (b) (c)
Figure 9: Sagittal CT reformation of the lumbar spines (a) shows a large sclerotic lesion nearly completely involving the L5 vertebral body.
Sagittal T1-weighted (b) and T2-weighted (c) images show abnormal hypointense marrow signal in not only the L5 vertebral body but also
the L4 vertebral body, corresponding to blastic metastatic lesions.
show mixed lytic and sclerotic lesions, which are seen with
ovarian, testicular, and cervical carcinomas (Figure 8). Lytic
lesions involve the posterior cortex almost always with des-
truction of the posterior cortex and pedicle. If the discs
appear brighter than bone on T1-weighted MR, it is con-
cerning for diﬀuse marrow inﬁltration. Lytic lesions typically
exhibit diﬀuse enhancement. Progressive sclerosis of a lytic
focus generally indicates a positive response. However, if
there is persistently low T1 signal in marrow after therapy,
this may indicate either active tumor or ﬁbrosis. Functional
techniques such as DWI and in phase/opposed phase are
being investigated as potential MR sequences for such diag-
nostic dilemmas [32].
Prostate, bladder, nasopharynx, medulloblastoma, neu-
roblastoma, and bronchial carcinoid primaries commonly
have blastic-appearing spinal metastases. The areas of sclero-
sis may be nodular or mottled in appearance. Occasionally,
there may be diﬀuse areas of increased density on radio-
graphs and CT with corresponding hypointensity on all MR
sequences (Figure 9). Blastic metastases tend to destroy the
posterior cortex and involve the pedicle. It is important to
assess for an associated paraspinal or epidural component.International Journal of Surgical Oncology 7
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Figure 10: Sagittal T2-weighted (a) and STIR (b) MR images reveal
abnormalhyperintensesignalinalowerthoracicvertebralbodydue
to fracture-related edema. A “ﬂuid sign” is demonstrated in this
vertebral body (yellow arrow), which is characteristic of a benign
osteoporotic fracture.
Tumormayspreadintotheanteriorepiduralspacewithspar-
ing of the meningovertebral ligament, resulting in the “drap-
ed curtain sign.” The enhancement pattern is variable de-
pending on the degree of sclerosis. Fat-suppression increases
the conspicuity of enhancing lesions. It may be diﬃcult to
evaluate the therapeutic response of sclerotic lesions as tu-
mor progression with osteolytic conversion appears similar
to fading, which is seen in good response.
Hematogeneous spread of metastatic disease is far more
frequent than lymphatic spread or direct invasion. The ven-
ousroute,especiallyBatson’sparavertebralplexus,appearsto
be more important than the arterial route. The distribution
of Batson’s venous plexus, as well as the overall skeletal
vascularity,resultsinapredilectionforhematogenousspread
to the axial skeleton and the proximal long bones.
Metastases may reach the skeleton by direct invasion
from the primary tumor or by extension from a secondary
site, such as a lymph node. True lymphatic spread to the
skeleton is rare. Direct invasion is usually accompanied by a
detectable soft tissue mass, an unusual feature of metastases
that occur by hematogenous spread.
However, hematogeneous spread of metastatic disease is
far more frequent than lymphatic spread or direct invasion.
The venous route, especially Batson’s paravertebral plexus,
appears to be more important than the arterial route. The
distribution of Batson’s venous plexus, as well as the overall
skeletal vascularity, results in a predilection for hematogen-
ous spread to the axial skeleton and the proximal long bones.
3.1. Disease Progression. Symptomatic spinal cord compres-
sion is seen in approximately 10%–20% of cases with meta-
static spinal involvement [2]. Research has shown that non-
contrast T1-weighted images are probably the most useful
typeofimagesinadultpatientswithclinicallysuspectedcord
compression,becausevertebralmetastasesaremostoftenap-
preciated with this MR imaging sequence [33–35]. A study
comparing diﬀerent MR protocols found unenhanced T1-
weighted images may be suﬃcient for evaluation of possible
cord compression and guiding radiation treatment [36].
Benign compression fractures and malignant lesions can
showaconsiderableoverlap.Edemainabenigncompression
fracture in the acute phase replaces the normal marrow,
resultinginhypointensityonT1-weightedimagesandhyper-
intensity on T2-weighted images. The vertebral body with
benign fracture may show enhancement. The morphology
of bone marrow replacement may be helpful for prediction
of the benign or pathologic cause of a fracture. Conventional
MRIfeatureshavebeencitedtosuggestpathologicfracture:a
convex posterior border of the vertebral body, abnormal sig-
nal intensity of the pedicle or posterior element, an encasing
epidural mass, a focal paraspinal mass, and other spinal
metastases [37]. Paravertebral soft-tissue masses and inﬁltra-
tion of posterior elements are the most reliable signs of a
malignant fracture. MR imaging ﬁndings suggestive of acute
osteoporotic compression fractures include a low-signal-
intensity band on T1- and T2-weighted images, spared nor-
mal bone marrow signal intensity of the vertebral body, re-
tropulsion of a posterior bone fragment, and multiple com-
pressionfractures[37].TheMRﬂuidsignhasbeendescribed
in avascular necrosis of the vertebral body [38, 39] and is a
common ﬁnding in acute and subacute benign osteoporotic
vertebral fractures [39]. Up to 40% of these fractures may
show the ﬂuid sign [40] (Figure 10). Morphologic criteria
may accurately predict benign from malignant fractures of
the spine in up to 94% of cases [41].
Quantitative ADC mapping, instead of qualitative diﬀu-
sion-weighted imaging, may provide valuable information
in diﬀerentiating benign vertebral fractures from metastatic
lesions [42]. Lower ADC values have been demonstrated in
pathologic fractures [42].
Vertebral metastases may invade the epidural space by
direct extension from adjacent bone through the posterior8 International Journal of Surgical Oncology
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Figure 11:SagittalT1-weightedMRimage(a)showsabnormalhypointensityrelatedtoinvasionbyaparaspinalmass(spindlecellsarcoma).
The cortical margins of the pedicles are attenuated (yellow arrows) in keeping with erosive changes of the mass invading through the neural
foraminaintothelateralepiduralspace.ThepostcontrastT1-weightedMRimagewithfat-saturation(b)showsheterogeneousenhancement
of the mass. Marrow inﬁltration and neuroforaminal involvement (red arrows) is well seen as hyperintense signal on the STIR MR image
(c).
Figure 12: Sagittal contrast-enhanced T1-weighted MR image with
fat saturation reveals multiple small enhancing lesions (yellow
arrows) along the cauda equina, related to leptomeningeal carcino-
matosis in a patient with breast cancer.
longitudinal ligament, by extension through the interver-
tebral foramina, by hematogenous dissemination, or very
rarely by lymphatic inﬁltration. Involvement of the epidural
space may result in compression of the spinal cord or cauda
equina or in radiculopathy because of compression of nerve
roots [43]. The neurologic symptoms due to the soft tissue
material impinging upon the epidural venous plexus results
in venous hypertension and vasogenic edema [44]. The
epidural tumor [44] and/or the vertebral collapse [45]m a y
(a) (b)
Figure 13: Sagittal T1-weighted MR image (a) shows a hazy ap-
pearance of the subarachnoid space (yellow arrow) in the distal
thecalsac.Fluidlayersdependentlyinthethecalsacfrombloodpro-
ducts and/or proteinaceous debris (red arrows). Sagittal enhanced
T1-weighted MR image (b) with fat-saturation shows diﬀuse en-
hancement of the CSF as well as thick sheet-like enhancement of
the cauda equina (orange arrows) related to metastatic melanoma.
have direct mass eﬀect in the spinal cord leading to neuro-
logic deterioration. However, occasionally the involvement
may be asymptomatic.
Bone destruction is seen often, up to 86% of the time
[46], at the level of epidural tumor involvement (Figure 11).
Pedicular erosion on radiographs predicts epidural disease in
31% of cases [47]. Epidural metastasis is often contiguous
with a vertebral body lesion. The meningovertebral ligamentInternational Journal of Surgical Oncology 9
Figure 14: Sagittal T1-weighted MR image reveals an intramedul-
lary hyperintense lesion in the dorsal upper thoracic cord from a
melanoma metastasis (yellow arrow). There is extensive surround-
ing hypointensity due to spinal cord edema. Additionally, there is a
T1 hyperintense vertebral body metastatic lesion (red arrow). Large
lobulated paraspinal masses are also noted (yellow star).
(a) (b)
Figure 15:SagittalT1-weighted(a)andSTIR(b)MRimagesdepict
a well-circumscribed lesion in a mid thoracic vertebral body. The
hyperintense signal and linear hypointensities, which correspond to
thickened trabeculae, are characteristic of a benign hemangioma.
is characteristically spared giving the “draped curtain” ap-
pearance. Lesions tend to be T1 hypointense, T2 hyperin-
tense, and avidly enhancing. In cases on spinal epidural lym-
phoma, the spinal column may actually be spared. Contrast
enhancement is helpful in delineating the extent of tumor
andmayhelpinoutliningregionsofspinalcordcompression
[35]. This is particularly useful in the cervical and thoracic
spine where there is relative paucity of epidural fat and pro-
minent ligaments, which typically increase the conspicuity
of epidural lesions. The thoracic spine is more often (∼60%)
involved in neoplastic epidural spinal cord compression as
compared to ∼30% in the lumbosacral spine [48]. This pre-
dilection may be due to the reduced potential space available
for tumor to expand.
Leptomeningeal carcinomatosis (LC) has an incidence as
high as 4–15% in patients with solitary tumors, 5–15% in
patients with leukemia and lymphoma, and 1-2% in patients
with primary brain tumors [40, 49]. In autopsy studies, the
ratehasbeenestimatedtobe19%inpatientswithcancerand
neurologic signs [50]. It is most commonly found in breast
carcinoma, lung carcinoma, and melanoma in adults and
hematogenous malignancies and primitive neuroectodermal
tumor (PNET) in children. Less commonly, prostate cancer
can spread to the leptomeninges. Melanoma and lung cancer
have the highest rates of spread to the leptomeninges at 20%
and 11%, respectively [51, 52]. The routes of dissemination
to the meninges include hematogenously though Batson’s
venous plexus or arterial spread, direct extension from con-
tiguous foci of tumor, and perineural or perivascular migra-
tion from systemic tumors [53, 54]. Tumor cells in the CSF
are carried throughout the neural axis, particularly the base
of the brain and the dorsal spinal cord surface and cauda
equina [54].
Spinal symptoms of LC include extremity weakness
(greater lower extremity involvement), dermatomal or seg-
mental sensory loss, and neck and/or back pain [49, 55].
While there are clinical signs and radiologic ﬁndings that
strongly suggest LC, most cases are diagnosed by CSF cytol-
ogy or leptomeningeal biopsy. As the diagnostic accuracy of
lumbar puncture (LP) is only 50–60% after a single LP and
90% after 3 LPs, MRI is considered complementary and
can be invaluable, detecting up to 50% of cases with false-
negative LPs. It is important to note that CSF levels of pro-
tein, glucose, and malignant cells vary at diﬀerent levels of
the neuraxis even without an obstructive lesion [56].
I m a g i n gt h ew h o l en e u r a x i si sr e q u i r e da sL Cc a ni n v o l v e
the entire CNS. Detection of CNS enhancement indicates a
poor prognosis [57]. MRIand CT may demonstratemultiple
masses within the subarachnoid space, hydrocephalus with-
out a discernible cause, or diﬀuse leptomeningeal enhance-
ment. The latter enhancement pattern has been referred to
as sugar icing or “zuckerguss” and can be found in the brain,
spine, or both. The nerve roots may be thickened, particu-
larly of the cauda equina, and there may be subarachnoid
nodules (Figure 12). CSF enhancement is uncommon but
when seen indicates massive tumor that coats the surface of
the CNS (Figure 13). Radioisotope CSF ﬂow studies may be
performed to prior to intrathecal chemotherapy in order to
ensure no obstruction of CSF ﬂow and homogeneous distri-
bution of the chemotherapeutic agent.
Gadolinium-enhanced T1-weighted MRI is superior to
contrast-enhanced CT in detecting abnormal leptomenin-
geal enhancement and the complications of meningitis in-
cluding cerebritis and ventriculitis. Sze et al. reported the
eﬃcacy with which gadolinum-enhanced MRI of the spine
candetectevensmalllesionsintheintraduralextramedullary
space [58]. However, other studies have shown that the eval-
uation of leptomeningeal metastasis with MRI and CT
modalities may have a high incidence of false-negative10 International Journal of Surgical Oncology
studies, 89% (31 of 35) by CT and 24% (4 of 17) by MRI
[59].Thelit eratur er epo rtsadiﬀerenceinsensitivitybetween
solid tumors and hematologic malignancies, with one study
reporting a sensitivity of 90% in patients with solid tumors
but only 55% in patients with lymphoma and leukemia [60].
Intramedullary spinal metastatic lesions are exceedingly
rare, representing only 8.5% of all CNS metastases. They
aﬀect an estimated 0.5–2% of patients with cancer and com-
prise1–3%ofallintramedullaryspinalcordtumors[61–63].
Intramedullary spinal cord metastases are due to lung cancer
in 50–60% of cases with small cell lung cancer compris-
ing 50% of these cases [61–63]. The presence of an intra-
medullary spinal metastatic lesion suggests an advanced bio-
logically aggressively form of cancer. The metastatic deposits
are usually solitary but may be multifocal in 15% of cases
[63].
The mechanism of metastatic spread from the primary
tumor to the spinal cord is thought to be hematogenous via
an arterial route in the majority of cases. In some cases, there
mayberetrogradespreadfromthevertebralvenousplexusor
directly from the CSF via perivascular spaces in patients with
LC.Extensionfromanadjacentneoplasmdirectlythoughthe
dura or by perineural spread has also been speculated.
The characteristic MRI ﬁnding is a small, intensely en-
hancinglesion,typicallylessthan1.5cm,withextensiveasso-
ciated edema. There may be an enlargement of the cord. T1
hyperintensity may be detected with melanoma spinal cord
metastases (Figure 14). Hemorrhagic intramedullary metas-
tases may demonstrate hypointensity on T2 and T2∗ grad-
ient-recalled echo images.
3.2. Spinal Metastatic Disease Mimics. The imaging diﬀeren-
tial diagnosis of vertebral body metastasis would include
benign hemangioma, discogenic endplate changes, and dis-
citis-osteomyelitis. Vertebral hemangiomas are typically
well-circumscribed, benign vascular tumors, which are T1
hyperintense(Figure15).Theselesionsmaybedarkorbright
on STIR sequences dependent on the proportion of fatty and
vascular elements. The coarse vertical trabeculae resemble
corduroy or honeycomb of radiographs. Internal trabeculae
may be subtle on MRI and may be better delineated on CT
in cases of “atypical” hemangiomas. Given the vascular com-
ponent of these lesions, enhancement is common. Type 1
ﬁbrovascular discogenic endplate changes display T1 hypo-
intensity, T2 and STIR hyperintensity, and enhancement.
The signal changes parallel the endplates, and the disc space
usually shows loss of height and low T2 signal due to
degeneration. Similarly, acute intravertebral disc herniation
or Schmorl’s node will demonstrate signal abnormality relat-
edtoedema,includingT1hypointensityandT2/STIRhyper-
intensity. In discitis-osteomyelitis, there are endplate ero-
sionswithintradiscﬂuidandpatchyenhancement.Theadja-
cent endplates demonstrate abnormal ﬂuid marrow signal
and enhancement. Osseous metastases typically do not cross
the disc space from one vertebral body to the next. The
avascular disc is resistant to tumor invasion.
Other lesions that may involve the epidural space include
epidural hematoma and epidural phlegmon/abscess. Epidu-
ral hematoma is generally contained in the “less common”
spectrum of intraspinal, extradural lesions, particularly in
the absence of sentinel events such as surgical manipulation
or trauma. Spontaneous epidural hematomas are rare but
havebeenreportedinpatientsonanticoagulation[64],those
with vascular malformations [65] and in pregnancy [66]. A
rare case report of spinal epidural hematoma associated with
unsuspected metastatic lung cancer has been described [61].
Depending on the status of the hemoglobin and its intra-
cellular versus extracellular location, the MR features will
vary. In the acute stage, it will be hyperdense on CT with
progressive hypodensity as the blood products evolve. The
dorsal epidural space is more often involved with the multi-
segmentalﬂuidcollection.Theremaybeperipheralenhance-
ment; however, focal enhancement should be concerning for
active extravasation [67].
Epidural abscess or phlegmon is often seen in associa-
tion with spondylodiscitis. Hematogenous dissemination
from gastrointenstinal, genitourinary, cutaneous, lung, and
cardiac infection sources is also possible. Direct inoculation
from iatrogenic procedures or trauma is an additional etio-
logy of spinal epidural abscess. The posterior epidural space
is involved more often than the anterior epidural space. Peri-
pheral enhancement with a necrotic core (abscess) or diﬀuse
enhancement (phlegmon) may be seen on contrast-enhan-
ced T1-weighted MRI. Fat saturation techniques make le-
sions in the epidural space more evident by suppressing the
normal epidural fat.
When evaluating an MRI with an intramedullary en-
hancing lesion, the diﬀerential considerations include de-
myelinating disease, granulomatous process, cord infarction,
cord vascular malformation, and primary cord tumor (such
as astrocytoma, ependymoma, hemangioblastoma). Clinical
history may provide clues to narrow the diﬀerential diag-
nosis. For instance, CSF positive for oligoclonal bands and
waxingandwaningsymptomsinayoungfemaleadultwould
favor a demyelinating process. Osseous metastases in a pa-
tient with a known primary malignancy would make an en-
hancing intramedullary lesion more suspicious for an intra-
medullary metastasis. Prominent vascular ﬂow voids along
the cord surface in addition to intramedullary edema are
helpful in determining if the lesion is a spinal arteriovenous
malformation.
4. Conclusion
Awarenessofthediﬀerentmanifestationsofspinalmetastatic
disease is essential as the spine is the most common site of
osseous metastatic disease. Imaging modalities have compli-
mentary roles in the evaluation of spinal metastatic disease.
CT best delineates osseous integrity while MRI is better
at assessing soft tissue involvement. Physiologic properties,
particularly in treated disease, can be evaluated with other
imagingmodalitiessuchasFDGPETandadvancedMRIseq-
uences. Imaging plays a fundamental role in not only diag-
nosis but also treatment planning of spinal metastatic dis-
ease.International Journal of Surgical Oncology 11
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